Induction of protective immune responses at respiratory mucosal sites
Many pathogens enter the host through mucosal sites. Thus, interfering with pathogen entry through local neutralization at mucosal sites therefore is an effective strategy for preventing disease. Mucosally administered vaccines have the potential to induce protective immune responses at mucosal site...
Saved in:
| Main Authors: | Seok-Chan Park, Matthew J. Wiest, Vivian Yan, Pamela T. Wong, Michael Schotsaert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2368288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal Inoculation of Cationic Crosslinked Carbon Dots‐Adjuvanted Respiratory Syncytial Virus F Subunit Vaccine Elicits Mucosal and Systemic Humoral and Cellular Immunity
by: Hong Lei, et al.
Published: (2025-04-01) -
Mucosal immunity and vaccination strategies: current insights and future perspectives
by: Zhihao Zhang, et al.
Published: (2025-08-01) -
Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery
by: Ahmedali S. Mandviwala, et al.
Published: (2025-03-01) -
Mucosal immunotherapy targeting APC in lung disease
by: Yangqi Liu, et al.
Published: (2025-04-01) -
The intricate interplay among microbiota, mucosal immunity, and viral infection in the respiratory tract
by: Xinyue Li, et al.
Published: (2025-04-01)